First generation anti-CD19 chimeric antigen receptor-modified T cells for management of B cell malignances: initial analysis of an ongoing Phase I clinical trial

Evans, Manon; Guest, Ryan; Rothwell, Dominic; Burt, Debbie; Kirillova, Natalia; Haughton, Jennifer; Chow, Shien; Thistlethwaite, Fiona; Gilham, David; Hawkins, Robert

doi:10.1186/2051-1426-2-S3-P12

Article metrics
Last updated: Tue, 23 Apr 2024 23:10:39 Z

First generation anti-CD19 chimeric antigen receptor-modified T cells for management of B cell malignances: initial analysis of an ongoing Phase I clinical trial

Access & Citations

887

Article Accesses
0

Web of Science
1

CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.